[SELECTED ETHICAL ISSUES IN ONCOGENETICS]. / QUESTIONS ÉTHIQUES CHOISIES EN ONCOGÉNÉTIQUE.
J Int Bioethique Ethique Sci
; 26(3): 217-25, 271, 2015 Jul.
Article
en Fr
| MEDLINE
| ID: mdl-27356357
Oncogenetics is the medical care of families with hereditary cancer risk. Bioethics laws strictly control this activity. Taking into account the medical benefit and lives saved through oncogenetics when a constitutional mutation in hereditary cancer risk gene is found, the law requires that information is disseminated to the relatives. If the consultant cannot or will not provide this information, this is the geneticist who will contact the family. This is an unprecedented situation where the doctor encourages medical advices not requested by patients. The Clermont experience is shown on the application of the law and its practical difficulties. Currently the technology of molecular genetic diagnosis is changing rapidly and allows new diagnostics whether at the level of cancerous tumors or in the genome with the perspective that everyone can soon have the sequence of the entire genome with the interpretation of personal risk of cancer diseases or other kinds. It is necessary to better anticipate emerging ethical issues already raised by the first medical practices of these technologies.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Discusiones Bioéticas
/
Genética Médica
/
Oncología Médica
Tipo de estudio:
Diagnostic_studies
Aspecto:
Ethics
Límite:
Humans
Idioma:
Fr
Revista:
J Int Bioethique Ethique Sci
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Francia